(R)-7-(But-2-Ynyl)-8-(3-(1,3-Dioxoisoindolin-2-Yl)Piperidin-1-Yl)-3-Methyl-1-((4-Methylquinazolin-2-Yl)Methyl)-1H-Purine-2,6(3H,7H)-Dione
97%
- Product Code: 231601
CAS:
886588-63-2
| Molecular Weight: | 602.64 g./mol | Molecular Formula: | C₃₃H₃₀N₈O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a potent and selective inhibitor of Bruton's tyrosine kinase (BTK), this compound plays a key role in the development of treatments for autoimmune diseases and certain B-cell malignancies. Its structure allows for high binding affinity to the BTK enzyme, effectively modulating signaling pathways involved in cell proliferation and survival. Due to its (R)-enantiomeric configuration, it exhibits improved pharmacokinetic properties and reduced off-target effects compared to racemic counterparts. It is primarily investigated in preclinical studies for conditions such as chronic lymphocytic leukemia, rheumatoid arthritis, and other disorders driven by aberrant B-cell activation.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | ฿2,150.00 |
+
-
|
| 250mg | 10-20 days | ฿3,560.00 |
+
-
|
| 1g | 10-20 days | ฿8,730.00 |
+
-
|
| 5g | 10-20 days | ฿30,520.00 |
+
-
|
(R)-7-(But-2-Ynyl)-8-(3-(1,3-Dioxoisoindolin-2-Yl)Piperidin-1-Yl)-3-Methyl-1-((4-Methylquinazolin-2-Yl)Methyl)-1H-Purine-2,6(3H,7H)-Dione
Used in pharmaceutical research as a potent and selective inhibitor of Bruton's tyrosine kinase (BTK), this compound plays a key role in the development of treatments for autoimmune diseases and certain B-cell malignancies. Its structure allows for high binding affinity to the BTK enzyme, effectively modulating signaling pathways involved in cell proliferation and survival. Due to its (R)-enantiomeric configuration, it exhibits improved pharmacokinetic properties and reduced off-target effects compared to racemic counterparts. It is primarily investigated in preclinical studies for conditions such as chronic lymphocytic leukemia, rheumatoid arthritis, and other disorders driven by aberrant B-cell activation.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :